Elevance Health (ELV) Cash from Financing Activities (2010 - 2026)

Elevance Health (ELV) has 17 years of Cash from Financing Activities data on file, last reported at -$2.5 billion in Q1 2026.

• Quarterly Cash from Financing Activities fell 31.74% year-over-year to -$2.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.3 billion (down 213.37% YoY) and the FY2025 annual result came in at -$1.7 billion, down 245.68% from the prior year.
• Cash from Financing Activities slipped to -$2.5 billion in Q1 2026 per ELV's latest filing, from $236.0 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $1.4 billion in Q4 2024 and bottomed at -$2.5 billion in Q1 2026.
• The 5-year median for Cash from Financing Activities is -$308.0 million (2025), against an average of -$454.5 million.
• The widest annual swing landed in 2024, when Cash from Financing Activities soared 457.36%; it then slumped 6065.62% in 2025.
• Tracing ELV's Cash from Financing Activities over 5 years: stood at -$258.0 million in 2022, then tumbled by 52.71% to -$394.0 million in 2023, then soared by 457.36% to $1.4 billion in 2024, then plunged by 83.24% to $236.0 million in 2025, then tumbled by 1165.68% to -$2.5 billion in 2026.
• Per Business Quant, the three latest ELV Cash from Financing Activities figures stand at -$2.5 billion (Q1 2026), $236.0 million (Q4 2025), and $243.0 million (Q3 2025).

Peer Comparison